Document is current
Any future updates will be listed below
-
Authors
Sun, Jun
Gaidosh, Gabriel
Xu, Ye
Mookhtiar, Adnan
Man, Na
Cingaram, Pradeep Reddy
Blumenthal, Ezra https://orcid.org/0000-0001-7607-088X
Shiekhattar, Ramin
Goka, Erik T.
Nimer, Stephen D. https://orcid.org/0000-0003-2439-7586
Lippman, Marc E. https://orcid.org/0000-0001-5280-4084
-
Funding
Funding for this research was provided by:
Lampert gift
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5R01CA166835, 1P30CA240139)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 30 October 2020
Revised: 14 July 2021
Accepted: 26 July 2021
First Online: 9 August 2021
Competing interests
: MEL is a director at Geneyus, LLC and a stockholder in Revere Pharmaceuticals. ETG is an employee of Revere Pharmaceuticals and has ownership interests (including patents) at Revere Pharmaceuticals and Geneyus, LLC.
